Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide Solution
FDA Label NDC 0121-0933

24 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide (NDC 0121-0933). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, general, information for patients, monoamine oxidase inhibitors (maoi), and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.